PubRank

T Sauerbruch

Author PubWeight™ 268.96‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Shock-wave lithotripsy of gallbladder stones. The first 175 patients. N Engl J Med 1988 5.53
2 Fragmentation of gallstones by extracorporeal shock waves. N Engl J Med 1986 2.76
3 Transjugular intrahepatic portosystemic shunting is not superior to endoscopic variceal band ligation for prevention of variceal rebleeding in cirrhotic patients: a randomized, controlled trial. Scand J Gastroenterol 2002 2.54
4 A citric acid solution is an optimal test drink in the 13C-urea breath test for the diagnosis of Helicobacter pylori infection. Gut 1997 2.32
5 Topographic association between active gastritis and Campylobacter pylori colonisation. J Clin Pathol 1989 2.09
6 [S3-Guidelines Conference "Colorectal Carcinoma" 2004]. Z Gastroenterol 2004 2.03
7 Clostridium difficile infection in patients with neutropenia. Clin Infect Dis 2001 2.00
8 Surface expression and cytolytic function of natural killer cell receptors is altered in chronic hepatitis C. Gut 2005 1.99
9 Evaluation of an ultrasound-guided technique for central venous access via the internal jugular vein in 493 patients. Support Care Cancer 2002 1.95
10 Long term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study. Gut 2000 1.89
11 T- and B-cell responses to different hepatitis C virus antigens in patients with chronic hepatitis C infection and in healthy anti-hepatitis C virus--positive blood donors without viremia. Hepatology 1996 1.88
12 Difference in expression of Helicobacter pylori gastritis in antrum and body. Gastroenterology 1992 1.70
13 Dormia baskets impacted in the bile duct: release by extracorporeal shock-wave lithotripsy. Endoscopy 1995 1.70
14 Increased frequency of the HLA-DR15 (B1*15011) allele in German patients with self-limited hepatitis C virus infection. Eur J Clin Invest 1999 1.68
15 Comparison of capsule endoscopy and magnetic resonance imaging for the detection of polyps of the small intestine in patients with familial adenomatous polyposis or with Peutz-Jeghers' syndrome. Endoscopy 2004 1.64
16 Gallstones: pathogenesis. Lancet 1991 1.64
17 Toll-like receptor (TLR) 2 promoter and intron 2 polymorphisms are associated with increased risk for spontaneous bacterial peritonitis in liver cirrhosis. J Hepatol 2011 1.62
18 Gallstone recurrence after shock-wave therapy. Gastroenterology 1994 1.59
19 Prognostic value of CA 19-9 levels in patients with inoperable adenocarcinoma of the pancreas treated with gemcitabine. Br J Cancer 2003 1.57
20 Long-term results and prognostic factors in the treatment of achalasia with botulinum toxin. Endoscopy 2002 1.51
21 Low-molecular weight proteins as markers for glomerular filtration rate. Clin Chem 2001 1.50
22 Prediction of variceal hemorrhage in cirrhosis: a prospective follow-up study. Gastroenterology 1991 1.47
23 Clinical characteristics and outcome of a cohort of 101 patients with hepatocellular carcinoma. World J Gastroenterol 2001 1.47
24 Comparison of portal vein velocity and the hepatic venous pressure gradient in assessing the acute portal hemodynamic response to propranolol in patients with cirrhosis. Am J Gastroenterol 2000 1.46
25 [Symptoms, tumor stage and primary treatment in patients with colorectal carcinoma]. Dtsch Med Wochenschr 1997 1.46
26 Surgical intervention following fragmentation of gallstones by extracorporeal shock waves. World J Surg 1989 1.42
27 [Fecal incontinence]. Internist (Berl) 2000 1.42
28 Serum bile acids: physiology and clinical relevance. Eur J Gastroenterol Hepatol 1995 1.41
29 [The therapy of the hepatorenal syndrome in liver cirrhosis]. Dtsch Med Wochenschr 1999 1.39
30 [Therapy-refractory thrombocytopenia in chronic hepatitis C]. Z Gastroenterol 2000 1.39
31 Autoimmunity induced by interferon-alpha therapy for chronic viral hepatitis. Biomed Pharmacother 1999 1.33
32 Mixed-strain infection with a drug-sensitive and multidrug-resistant strain of Mycobacterium tuberculosis. Lancet 1995 1.32
33 A novel minimal-size vector (MIDGE) improves transgene expression in colon carcinoma cells and avoids transfection of undesired DNA. Mol Ther 2001 1.28
34 Mechanism of cytotoxicity induced by chimeric mouse human monoclonal antibody IDEC-C2B8 in CD20-expressing lymphoma cell lines. Cell Immunol 2000 1.28
35 Definitions, methodology and therapeutic strategies in portal hypertension. A Consensus Development Workshop, Baveno, Lake Maggiore, Italy, April 5 and 6, 1990. J Hepatol 1992 1.27
36 Fecal elastase test: evaluation of a new noninvasive pancreatic function test. Am J Gastroenterol 1995 1.27
37 Hemodynamic effects of the angiotensin II receptor antagonist irbesartan in patients with cirrhosis and portal hypertension. Gastroenterology 2001 1.25
38 Mechanisms of extrahepatic vasodilation in portal hypertension. Gut 2008 1.23
39 The Munich Gallbladder Lithotripsy Study. Results of the first 5 years with 711 patients. Ann Intern Med 1991 1.23
40 Interactions between dendritic cells and cytokine-induced killer cells lead to an activation of both populations. J Immunother 2001 1.21
41 S3 guidelines for colorectal carcinoma: results of an evidence-based consensus conference on February 6/7, 2004 and June 8/9, 2007 (for the topics IV, VI and VII). Z Gastroenterol 2010 1.20
42 Calculation of glomerular filtration rate based on cystatin C in cirrhotic patients. Nephrol Dial Transplant 2005 1.20
43 Decreased frequency of HCV core-specific peripheral blood mononuclear cells with type 1 cytokine secretion in chronic hepatitis C. J Hepatol 1999 1.20
44 Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo-controlled trial. Hepatology 1992 1.19
45 A retrospective analysis of 3 year's experience of an interdisciplinary approach to gallstone disease including shock-waves. Ann Surg 1988 1.19
46 Shock-wave therapy of gastric outlet syndrome caused by a gallstone. Gastroenterology 1989 1.19
47 Modified rapid urease test for detection of Helicobacter pylori infection. Eur J Gastroenterol Hepatol 1996 1.16
48 Chromocolonoscopy detects more adenomas than white light colonoscopy or narrow band imaging colonoscopy in hereditary nonpolyposis colorectal cancer screening. Endoscopy 2009 1.16
49 Intestinal involvement in progressive systemic sclerosis detected by increased unconjugated serum bile acids. Gut 1987 1.14
50 Correlation of serum concentrations of cystatin C and creatinine to inulin clearance in liver cirrhosis. Clin Chem 2000 1.13
51 Evidence for down-regulation of beta-2-adrenoceptors in cirrhotic patients with severe ascites. Lancet 1986 1.11
52 Littoral cell angioma as a rare cause of splenomegaly. Ann Hematol 2001 1.11
53 Immunosuppression may lead to progression of hepatitis C virus-associated liver disease in hemophiliacs coinfected with HIV. Am J Gastroenterol 1996 1.10
54 Microsatellite instability-a useful diagnostic tool to select patients at high risk for hereditary non-polyposis colorectal cancer: a study in different groups of patients with colorectal cancer. Gut 1999 1.10
55 Endoscopy in the diagnosis of gastritis. Diagnostic value of endoscopic criteria in relation to histological diagnosis. Endoscopy 1984 1.10
56 CD30 induction and cytokine profiles in hepatitis C virus core-specific peripheral blood T lymphocytes. J Immunol 1997 1.08
57 Three-dimensional magnetic resonance cholangiopancreatography with respiratory triggering in the diagnosis of primary sclerosing cholangitis: comparison with endoscopic retrograde cholangiography. Endoscopy 2002 1.07
58 Sorafenib targets dysregulated Rho kinase expression and portal hypertension in rats with secondary biliary cirrhosis. Br J Pharmacol 2009 1.07
59 Influence of cytokines, monoclonal antibodies and chemotherapeutic drugs on epithelial cell adhesion molecule (EpCAM) and LewisY antigen expression. Clin Exp Immunol 2001 1.07
60 Microsatellite instability did not predict individual survival of unselected patients with colorectal cancer. Int J Colorectal Dis 2006 1.06
61 "Atypical p-ANCA" in IBD and hepatobiliary disorders react with a 50-kilodalton nuclear envelope protein of neutrophils and myeloid cell lines. Gastroenterology 2000 1.06
62 Early gallstone recurrence rate after successful shock-wave therapy. Gastroenterology 1990 1.06
63 Enhanced expression of CD80 (B7-1), CD86 (B7-2), and CD40 and their ligands CD28 and CD154 in fulminant hepatic failure. Am J Pathol 1999 1.06
64 Breakthrough invasive fungal infections in neutropenic patients after prophylaxis with itraconazole. Mycoses 1999 1.06
65 Esophageal function after sclerotherapy of bleeding varices. Scand J Gastroenterol 1982 1.05
66 Enhanced lytic activity of cytokine-induced killer cells against multiple myeloma cells after co-culture with idiotype-pulsed dendritic cells. Haematologica 2001 1.02
67 Sodium selenite and N-acetylcysteine in antiretroviral-naive HIV-1-infected patients: a randomized, controlled pilot study. Eur J Clin Invest 1998 1.02
68 Simultaneous determination of cholic acid and chenodeoxycholic acid pool sizes and fractional turnover rates in human serum using 13C-labeled bile acids. J Lipid Res 1984 1.01
69 Very early detection of response to imatinib mesylate therapy of gastrointestinal stromal tumours using 18fluoro-deoxyglucose-positron emission tomography. Anticancer Res 2005 1.01
70 Serum selenium, plasma glutathione (GSH) and erythrocyte glutathione peroxidase (GSH-Px)-levels in asymptomatic versus symptomatic human immunodeficiency virus-1 (HIV-1)-infection. Eur J Clin Nutr 1997 1.01
71 Somatostatin does not reduce oesophageal variceal pressure in liver cirrhotics. Gut 1988 1.01
72 Antibiotic prophylaxis of infectious complications with endoscopic retrograde cholangiopancreatography. A randomized controlled study. Endoscopy 1990 1.01
73 T(H)1 to T(H)2 shift of cytokines in peripheral blood of HIV-infected patients is detectable by reverse transcriptase polymerase chain reaction but not by enzyme-linked immunosorbent assay under nonstimulated conditions. J Acquir Immune Defic Syndr 2000 1.00
74 Dendritic cells pulsed with alpha-galactosylceramide induce anti-tumor immunity against pancreatic cancer in vivo. Int Immunol 2006 0.99
75 Frequency of hereditary non-polyposis colorectal cancer among unselected patients with colorectal cancer in Germany. Digestion 2006 0.99
76 Intestinal hyperabsorption of oxalate in calcium oxalate stone formers: application of a new test with [13C2]oxalate. J Am Soc Nephrol 1999 0.98
77 [Colorectal carcinoma: prevention and early detection in an asymptomatic population--prevention in patients at risk--endoscopic diagnosis, therapy and after-care of polyps and carcinomas. German Society of Digestive and Metabolic Diseases/Study Group for Gastrointestinal Oncology]. Z Gastroenterol 2000 0.98
78 Serum selenium versus lymphocyte subsets and markers of disease progression and inflammatory response in human immunodeficiency virus-1 infection. Biol Trace Elem Res 1997 0.97
79 Benign hepatic tumours. Z Gastroenterol 2003 0.97
80 Atrial natriuretic factor and renin-aldosterone in volume regulation of patients with cirrhosis. Hepatology 1989 0.97
81 Interferon/antioxidant combination therapy for chronic hepatitis C--a controlled pilot trial. Antiviral Res 1999 0.96
82 Fatal acute liver failure due to reactivation of hepatitis B following treatment with fludarabine/cyclophosphamide/rituximab for low grade non-Hodgkin's lymphoma. Eur J Med Res 2008 0.96
83 Inadequate erythropoietin response to anaemia in HIV patients: relationship to serum levels of tumour necrosis factor-alpha, interleukin-6 and their soluble receptors. Br J Haematol 1997 0.96
84 Cystatin C-based calculation of glomerular filtration rate in kidney transplant recipients. Kidney Int 2006 0.96
85 Nosocomial septicemia in patients undergoing sclerotherapy for variceal hemorrhage. Endoscopy 1984 0.95
86 Atypical antineutrophil cytoplasmic antibodies with perinuclear fluorescence in chronic inflammatory bowel diseases and hepatobiliary disorders colocalize with nuclear lamina proteins. Hepatology 1998 0.95
87 Itraconazole trough concentrations in antifungal prophylaxis with six different dosing regimens using hydroxypropyl-beta-cyclodextrin oral solution or coated-pellet capsules. Mycoses 1999 0.94
88 Natural cytotoxicity and antibody-dependent cellular cytotoxicity (ADCC) is not impaired in patients suffering from chronic hepatitis C. J Hepatol 2001 0.94
89 Extracorporeal shock-wave lithotripsy of gallstones without general anesthesia: first clinical experience. Ann Intern Med 1987 0.94
90 Altered adrenergic responsiveness of endothelium-denuded hepatic arteries and portal veins in patients with cirrhosis. Gastroenterology 1999 0.94
91 Gallstone ileus successfully treated by shock-wave lithotripsy. Dig Dis Sci 1991 0.93
92 Effect of omeprazole on Helicobacter pylori urease activity in vivo. Eur J Gastroenterol Hepatol 1996 0.93
93 Successful endoscopic transection of a partially obstructing antral diaphragm. Gastroenterology 1985 0.92
94 Semi-quantification of human C-C chemokine mRNAs with reverse transcription/real-time PCR using multi-specific standards. J Immunol Methods 2000 0.92
95 Gallbladder motility before and after extracorporeal shock-wave lithotripsy. Gastroenterology 1989 0.92
96 [S3-guidelines for diagnosis and treatment of gallstones. German Society for Digestive and Metabolic Diseases and German Society for Surgery of the Alimentary Tract]. Z Gastroenterol 2007 0.92
97 Differentiation of antineutrophil nuclear antibodies in inflammatory bowel and autoimmune liver diseases from antineutrophil cytoplasmic antibodies (p-ANCA) using immunofluorescence microscopy. Clin Exp Immunol 2001 0.91
98 Cancer risk in HIV-infected individuals on HAART is largely attributed to oncogenic infections and state of immunocompetence. Eur J Med Res 2011 0.91
99 Acute transient encephalopathy after paclitaxel infusion: report of three cases. Ann Oncol 2002 0.91
100 The IL-1 system in HIV infection: peripheral concentrations of IL-1beta, IL-1 receptor antagonist and soluble IL-1 receptor type II. Clin Exp Immunol 1997 0.91
101 Correlation between gall bladder fasting volume and postprandial emptying in patients with gall stones and healthy controls. Gut 1993 0.91
102 Prediction of imminent complications in HIV-1-infected patients by markers of lymphocyte apoptosis. J Acquir Immune Defic Syndr 2000 0.90
103 Prognostic significance of serum bile acids in cirrhosis. Hepatology 1986 0.90
104 Tumour suppression induced by the macrophage activating lipopeptide MALP-2 in an ultrasound guided pancreatic carcinoma mouse model. Gut 2004 0.90
105 Bacteriaemia associated with endoscopic sclerotherapy of oesophageal varices. Endoscopy 1985 0.90
106 Intrahepatic upregulation of RhoA and Rho-kinase signalling contributes to increased hepatic vascular resistance in rats with secondary biliary cirrhosis. Gut 2006 0.90
107 Semiquantitative analysis of intrahepatic cytokine mRNAs in chronic hepatitis C. J Infect Dis 1997 0.90
108 Decreased prevalence of Helicobacter pylori infection in HIV patients with AIDS defining diseases. Z Gastroenterol 2002 0.90
109 Antifungal prophylaxis with itraconazole in neutropenic patients with acute leukaemia. Leukemia 1998 0.89
110 Association of the c.3972C>T variant of the multidrug resistance-associated protein 2 Gene (MRP2/ABCC2) with susceptibility to bile duct cancer. Digestion 2009 0.89
111 Cholestasis associated with mesalazine therapy in a patient with Crohn's disease. J Hepatol 1997 0.89
112 Effect of olsalazine and mesalazine on human ileal and colonic (Na+ + K+)-ATPase. A possible diarrhogenic factor? Clin Investig 1993 0.89
113 Combination of bilateral metal stenting and trans-stent photodynamic therapy for palliative treatment of hilar cholangiocarcinoma. Z Gastroenterol 2010 0.89
114 Detection of human aspartyl (asparaginyl) beta-hydroxylase and homeobox B7 mRNA in brush cytology specimens from patients with bile duct cancer. Endoscopy 2006 0.89
115 Is the increase in serum cystathionine levels in patients with liver cirrhosis a consequence of impaired homocysteine transsulfuration at the level of gamma-cystathionase? Scand J Gastroenterol 2000 0.89
116 Vascular hyporesponsiveness to angiotensin II in rats with CCl(4)-induced liver cirrhosis. Eur J Clin Invest 2009 0.89
117 Therapeutic vaccination against metastatic carcinoma by expression-modulated and immunomodified autologous tumor cells: a first clinical phase I/II trial. Hum Gene Ther 2001 0.88
118 Long-term sclerotherapy of bleeding esophageal varices in patients with liver cirrhosis. An evaluation of mortality and rebleeding risk factors. Scand J Gastroenterol 1985 0.88
119 Transjugular intrahepatic portosystemic stent-shunt for hepatorenal syndrome. Lancet 1997 0.88
120 Progression of liver fibrosis in HIV/HCV genotype 1 co-infected patients is related to the T allele of the rs12979860 polymorphism of the IL28B gene. Eur J Med Res 2011 0.88
121 Isolated tuberculosis of the pancreas masquerading as a pancreatic mass. Am J Gastroenterol 1995 0.88
122 Heterozygosity for the alpha1-antitrypsin Z allele may confer genetic risk of cholangiocarcinoma. Aliment Pharmacol Ther 2010 0.88
123 Noninvasive therapy of gallbladder calculi with a radiopaque rim. Gastroenterology 1992 0.88
124 Superior virological efficacy of ritonavir-boosted protease inhibitor regimens compared to single protease inhibitor therapy. Eur J Med Res 2003 0.87
125 The low-dose monoethylglycinexylidide test: assessment of liver function with fewer side effects. Hepatology 1997 0.87
126 Immune responses in hepatitis C virus infection. J Hepatol 1996 0.87
127 Fragmentation of gallstones using extracorporeal shock waves: an in vitro study. Hepatology 1988 0.87
128 Prevalence of and risk factors for Helicobacter pylori infection in the western part of Germany. Eur J Gastroenterol Hepatol 1996 0.87
129 Resistance of pancreatic carcinoma cells is reversed by coculturing NK-like T cells with dendritic cells pulsed with tumor-derived RNA and CA 19-9. Mol Ther 2001 0.87
130 E-cadherin expression is homogeneously reduced in adenoma from patients with familial adenomatous polyposis: an immunohistochemical study of E-cadherin, beta-catenin and cyclooxygenase-2 expression. Int J Colorectal Dis 2004 0.87
131 Endoscopic manometry of esophageal varices: evaluation of a balloon technique compared with direct portal pressure measurement. J Hepatol 1998 0.86
132 Intrahepatic mRNA levels of interferon gamma and tumor necrosis factor alpha and response to antiviral treatment of chronic hepatitis C. J Hum Virol 2001 0.86
133 Manometry of esophageal varices: comparison of an endoscopic balloon technique with needle puncture. Gastroenterology 1993 0.86
134 The tandem-repeat polymorphism of the DC-SIGNR gene in HCV infection. J Viral Hepat 2006 0.86
135 Transient elastography discloses identical distribution of liver fibrosis in chronic hepatitis C between HIV-negative and HIV-positive patients on HAART. Eur J Med Res 2010 0.86
136 Geotrichum capitatum septicaemia in neutropenic patients: case report and review of the literature. Mycoses 1998 0.86
137 Treatment of postoperative bile fistulas by internal endoscopic biliary drainage. Gastroenterology 1986 0.85
138 Amanita phalloides intoxications in a family of russian immigrants. Case reports and review of the literature with a focus on orthotopic liver transplantation. Z Gastroenterol 1994 0.85
139 Hepatitis C virus core protein does not inhibit apoptosis in human hepatoma cells. Eur J Clin Invest 1999 0.85
140 [Progress of acute liver failure and indications for liver transplantation]. Dtsch Med Wochenschr 1998 0.85
141 Influence of rifampin on serum markers of cholesterol and bile acid synthesis in men. Int J Clin Pharmacol Ther 2004 0.85
142 Treatment of common bile duct stones. A consensus report. Hepatogastroenterology 1994 0.85
143 Diagnosis and therapy of intrahepatic cholestasis of pregnancy. Z Gastroenterol 2004 0.85
144 Diagnostic accuracy of atypical p-ANCA in autoimmune hepatitis using ROC- and multivariate regression analysis. Eur J Med Res 2004 0.85
145 [Australia (SH)-antigen in blood donors and recipients]. Dtsch Med Wochenschr 1970 0.85
146 Semiquantitation of human chemokine mRNA levels with a newly constructed multispecific competitor fragment. J Immunol Methods 1999 0.85
147 IgA class antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis and autoimmune hepatitis. Clin Exp Immunol 2003 0.85
148 [S2k guidelines diverticular disease/diverticulitis]. Z Gastroenterol 2014 0.85
149 A bispecific single-chain antibody directed against EpCAM/CD3 in combination with the cytokines interferon alpha and interleukin-2 efficiently retargets T and CD3+CD56+ natural-killer-like T lymphocytes to EpCAM-expressing tumor cells. Cancer Immunol Immunother 2000 0.84
150 Sclerotherapy of a bleeding duodenal varix. Endoscopy 1982 0.84
151 [Immunohistological examinations in a case of giant cell arteritis (temporal arteritis)]. Dtsch Med Wochenschr 1973 0.84
152 Treatment of Barrett's esophagus by endoscopic argon plasma coagulation. Endoscopy 1997 0.84
153 Cirrhotic patients with or without hepatocellular carcinoma harbour AFP-specific T-lymphocytes that can be activated in vitro by human alpha-fetoprotein. Scand J Gastroenterol 2002 0.84
154 [Therapy of cholelithiasis]. Internist (Berl) 1986 0.84
155 In vitro cholesterol gallstone dissolution after fragmentation with shock waves. Digestion 1986 0.84
156 A recombinant anti-carcinoembryonic antigen immunoreceptor with combined CD3zeta-CD28 signalling targets T cells from colorectal cancer patients against their tumour cells. Gut 2005 0.83
157 Binding of HCV E2 to CD81 induces RANTES secretion and internalization of CC chemokine receptor 5. J Viral Hepat 2004 0.83
158 Antigen-specific cytokine response to hepatitis C virus core epitopes in HIV/hepatitis C virus-coinfected patients. AIDS 1999 0.83
159 [S3-guideline conference "Colorectal Cancer" 2004]. Dtsch Med Wochenschr 2005 0.83
160 Increased VEGF levels induced by anti-VEGF treatment are independent of tumor burden in colorectal carcinomas in mice. Gene Ther 2006 0.83
161 Transfection of dendritic cells (DCs) with the CIITA gene: increase in immunostimulatory activity of DCs. Cancer Gene Ther 2001 0.83
162 Pressure of intraoesophageal varices assessed by fine needle puncture: its relation to endoscopic signs and severity of liver disease in patients with cirrhosis. Gut 1989 0.83
163 Beta-trace protein-based equations for calculation of GFR in renal transplant recipients. Am J Transplant 2008 0.82
164 Acute haemodynamic effects of losartan in anaesthetized cirrhotic rats. Eur J Clin Invest 2003 0.82
165 Biliary metal stents and air embolism: a note of caution. Endoscopy 2006 0.82
166 Decrease of elevated N,N-dimethylglycine and N-methylglycine in human immunodeficiency virus infection during short-term highly active antiretroviral therapy. Metabolism 2001 0.82
167 Fibrotic entrapment of the small bowel in congenital intestinal lymphangiectasia. Am J Gastroenterol 1998 0.82
168 The lignocaine metabolite (MEGX) liver function test and P-450 induction in humans. Br J Clin Pharmacol 1998 0.82
169 A hepatitis C virus (HCV) core protein derived peptide inhibits HCV specific lymphocyte proliferation. Eur J Med Res 2000 0.82
170 Feasibility and safety of long-term photodynamic therapy (PDT) in the palliative treatment of patients with hilar cholangiocarcinoma. Eur J Med Res 2011 0.82
171 [Malaria in the emergency room. Results of the emergency treatment of 137 patients with symptomatic malaria]. Dtsch Med Wochenschr 2005 0.82
172 Renal impairment after liver transplantation - a pilot trial of calcineurin inhibitor-free vs. calcineurin inhibitor sparing immunosuppression in patients with mildly impaired renal function after liver transplantation. Eur J Med Res 2009 0.82
173 Intrahepatic expression of interleukin-1beta and tumor necrosis factor-alpha in chronic hepatitis C. J Infect Dis 1999 0.82
174 Autoimmune hepatitis--sequel of a relapsing hepatitis A in a 75-year-old woman. Digestion 2004 0.81
175 Gallbladder emptying determines early gallstone clearance after shock-wave lithotripsy. Gastroenterology 1994 0.81
176 Anomalous expression of costimulatory molecules B7-1, B7-2 and CD28 in primary biliary cirrhosis. J Hepatol 1997 0.81
177 Transjugular portosystemic stent shunt in treatment of liver diseases. World J Gastroenterol 2001 0.81
178 [Clinical outcome of a cohort of 63 patients with hepatocellular carcinoma treated with octreotide]. Z Gastroenterol 2002 0.81
179 Low frequency of enteric infections by Salmonella, Shigella, Yersinia and Campylobacter in patients with acute leukemia. Infection 2002 0.81
180 Portal hypertension and nodular regenerative hyperplasia in a patient with celiac disease. Z Gastroenterol 2006 0.81
181 Keratin 18 provides resistance to Fas-mediated liver failure in mice. Eur J Clin Invest 2009 0.81
182 Prophylaxis of first variceal hemorrhage in patients with liver cirrhosis. Klin Wochenschr 1986 0.81
183 Renal functional reserve and nitric oxide in patients with compensated liver cirrhosis. Hepatology 1997 0.81
184 [Early detection of colonic cancer in the National Cancer Program--present status and recommendations]. Z Gastroenterol 2011 0.81
185 Agiolax bolus in the esophagus. Report of two cases. Endoscopy 1980 0.81
186 Contractile hyporesponsiveness of hepatic arteries in humans with cirrhosis: evidence for a receptor-specific mechanism. Hepatology 2001 0.80
187 Splenic abscesses and abdominal tuberculosis in patients with AIDS. Z Gastroenterol 1996 0.80
188 Pathogenic factors in early recurrence of cholesterol gallstones. Gastroenterology 1994 0.80
189 Flow cytometric analysis of peptide binding to major histocampatibility complex class I for hepatitis C virus core T-cell epitopes. Cytometry 2000 0.80
190 Noninvasive endoscopic determination of intravariceal pressure in patients with portal hypertension: clinical experience with a new balloon technique. Endoscopy 1998 0.80
191 Gallstone recurrence after direct contact dissolution with methyl tert-butyl ether. Dig Dis Sci 1995 0.80
192 A patient with portal hypertension and blindness after transjugular intrahepatic portosystemic shunt. Eur J Gastroenterol Hepatol 2006 0.80
193 Intravenous treatment of hyperhomocysteinemia in patients on chronic hemodialysis--a pilot study. Ren Fail 2004 0.80
194 [Drug- and toxin-induced hepatotoxicity]. Z Gastroenterol 2003 0.79
195 Severe abdominal infections in neutropenic patients. Cancer Invest 2001 0.79
196 Deterioration of cholestasis after endoscopic retrograde cholangiography in advanced primary sclerosing cholangitis. J Hepatol 1992 0.79
197 Protein levels of interleukin-12 p70 holomer, its p40 chain and interferon-gamma during advancing HIV infection. J Infect 1998 0.79
198 [Heterozygous alpha-1-antitrypsin deficiency (PiMZ): risk factor in the development of primary liver carcinoma in non-cirrhotic liver?]. Z Gastroenterol 2010 0.79
199 [Cholesterol content of bile-duct stones]. Dtsch Med Wochenschr 1983 0.79
200 Increase of the immunostimulatory effect of dendritic cells by pulsing with CA 19-9 protein. J Immunother 2000 0.79
201 Variability of gallbladder emptying after oral stimulation. Scand J Gastroenterol 1997 0.79
202 Parallel decrease in neurotoxin quinolinic acid and soluble tumor necrosis factor receptor p75 in serum during highly active antiretroviral therapy of HIV type 1 disease. AIDS Res Hum Retroviruses 2000 0.79
203 Propranolol stereoisomer plasma concentrations and portal haemodynamic response in patients with liver cirrhosis. Aliment Pharmacol Ther 1999 0.79
204 [Early diagnosis of colorectal tumors]. Internist (Berl) 2005 0.79
205 Nitrite and nitrate levels in patients with cirrhosis of the liver: influence of kidney function and fasting state. Scand J Gastroenterol 1999 0.79
206 Adjuvant capecitabine is at least as effective as fluorouracil plus leucovorin for survival in people with resected stage III colon cancer. Cancer Treat Rev 2005 0.79
207 Intrahepatic MxA expression is correlated with interferon-alpha expression in chronic and fulminant hepatitis. J Pathol 2001 0.79
208 The combination of interleukin-2 and interferon alpha effectively augments the antibody-dependent cellular cytotoxicity of monoclonal antibodies 17-1A and BR55-2 against the colorectal carcinoma cell line HT29. Cancer Immunol Immunother 1998 0.79
209 Extracorporeal shock wave lithotripsy of gall stones: an in vitro comparison between an electrohydraulic and a piezoceramic device. Gut 1991 0.79
210 [Gastrointestinal bleeding in portal hypertension in liver cirrhosis]. Z Gastroenterol 2005 0.78
211 [Liver cirrhosis as precancerous conditions]. Internist (Berl) 1997 0.78
212 [German S 3-guideline "ascites, spontaneous bacterial peritonitis, hepatorenal syndrome"]. Z Gastroenterol 2011 0.78
213 Fungal surveillance cultures during antifungal prophylaxis with itraconazole in neutropenic patients with acute leukaemia. Mycoses 1999 0.78
214 Effect of propranolol and depot lanreotide SR on postprandial and circadian portal haemodynamics in cirrhosis. Aliment Pharmacol Ther 2003 0.78
215 Elevated soluble tumour necrosis factor receptor serum concentrations and short-term mortality in liver cirrhosis without acute infections. Digestion 2000 0.78
216 [Occurrence and significance of autoantibodies in the course of interferon therapy of chronic hepatitis C]. Dtsch Med Wochenschr 1996 0.78
217 Quality assurance by computerized endoscopy record systems. Endoscopy 1992 0.78
218 [Conservative therapy on cholelithiasis]. Z Arztl Fortbild (Jena) 1990 0.78
219 Effect of cytochrome P450 induction on phosphorus metabolites and proton relaxation times measured by in vivo 31P-magnetic resonance spectroscopy and 1H-magnetic resonance relaxometry in human liver. Hepatology 1997 0.78
220 [Antibiotic therapy and prophylaxis in liver cirrhosis and infection]. Dtsch Med Wochenschr 2007 0.78
221 Inhibition of neuropilin-1 by RNA-interference and its angiostatic potential in the treatment of hepatocellular carcinoma. Z Gastroenterol 2010 0.78
222 Effects of repeated injection sclerotherapy on acid gastroesophageal reflux. Gastrointest Endosc 1986 0.78
223 Gallstone treatment by extracorporeal shock-wave lithotripsy. J Hepatol 1988 0.78
224 Prophylaxis of first variceal bleeding. Baillieres Clin Gastroenterol 1992 0.78
225 [Primary neuroendocrine carcinoma of the liver. From carcinoid tumor to small-cell hepatic carcinoma: case reports and review of the literature]. Pathologe 2008 0.78
226 Relationship between cytochrome P-450 induction by rifampicin, hepatic volume and portal blood flow in man. Eur J Gastroenterol Hepatol 1997 0.78
227 [Adjuvant and palliative chemotherapy of colorectal cancer in Germany outside controlled trials]. Dtsch Med Wochenschr 2006 0.78
228 Bile acid pattern and cholesterol saturation of bile after cholecystectomy and endoscopic sphincterotomy. Digestion 1983 0.78
229 Enhancement of antibody dependent cellular cytotoxicity (ADCC) by combination of cytokines. Hybridoma 1999 0.78
230 Life-threatening interaction between clarithromycin and disopyramide. Lancet 1997 0.78
231 [Rudolf Schindler (1888--1968)--"father" of gastroscopy]. Z Gastroenterol 2004 0.78
232 Piperacillin-tazobactam is more effective than ceftriaxone plus gentamicin in febrile neutropenic patients with hematological malignancies: a randomized comparison. Support Care Cancer 2003 0.78
233 [Liver perfusion scintigraphy: method, normal values and results of observations on the course of patients with esophageal varices]. Nuklearmedizin 1985 0.77
234 Which lidocaine dose should be used for the MEGX liver function test? J Hepatol 1995 0.77
235 Liver perfusion scintigraphy prior to and after transjugular intrahepatic portosystemic shunts (TIPS) in patients with portal hypertension. Nuklearmedizin 2000 0.77
236 Vitamin E status in patients with liver cirrhosis: normal or deficient? Metabolism 1999 0.77
237 Correlation of transient elastography with APRI and FIB-4 in a cohort of patients with congenital bleeding disorders and HCV or HIV/HCV coinfection. Haemophilia 2010 0.77
238 [Guidelines of the German Society of Digestive and Metabolic Diseases for diagnosis and therapy of hepatocellular carcinoma. German Society of Digestive and Metabolic Diseases]. Z Gastroenterol 1999 0.77
239 Combinations of the cytokines IL-12, IL-2 and IFN-alpha significantly augment whereas the cytokine IL-4 suppresses the cytokine-induced antibody-dependent cellular cytotoxicity of monoclonal antibodies 17-1A and BR55-2. Cytokine 2000 0.77
240 Population-based registration of unselected colorectal cancer patients: five-year survival in the region of Bonn/Rhine-Sieg, Germany. Z Gastroenterol 2005 0.77
241 Effect of endoscopic sphincterotomy on bile acid pool size and bile lipid composition in man. Digestion 1983 0.77
242 Hemodynamic effects of propranolol and nitrates in cirrhotics with transjugular intrahepatic portosystemic stent-shunt. Scand J Gastroenterol 2002 0.77
243 Increase in the immunostimulatory effect of dendritic cells by pulsing with serum derived from pancreatic and colorectal cancer patients. Int J Colorectal Dis 2000 0.77
244 Orthotopic liver transplantation in human-immunodeficiency-virus-positive patients in Germany. AIDS Res Treat 2012 0.77
245 Course and therapy of acute liver failure. Eur J Med Res 2008 0.77
246 Augmentation of 17-1A-induced antibody-dependent cellular cytotoxicity by the triple cytokine combination of interferon-alpha, interleukin-2, and interleukin-12. J Immunother 2000 0.77
247 Changes of lymphocyte apoptosis associated with sequential introduction of highly active antiretroviral therapy. HIV Med 2003 0.77
248 Lipidation of T helper sequences from hepatitis C virus core significantly enhances T-cell activity in vitro. Immunology 2001 0.77
249 The place of lithotripsy and surgery in the management of gallstone disease. Adv Surg 1990 0.77
250 Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B. Hepatogastroenterology 1999 0.77
251 Effects of different octreotide dosages on splanchnic hemodynamics and glucagon in healthy volunteers. Digestion 1999 0.77
252 Prestimulation of monocytes by the cytokines GM-CSF or IL-2 enhances the antibody dependent cellular cytotoxicity of monoclonal antibody 17-1A. Z Gastroenterol 2000 0.77
253 Semiquantitation of intrahepatic MDR3 mRNA levels by reverse transcription/competitive polymerase chain reaction. J Hepatol 1997 0.77
254 Antiretroviral triple therapy decreases HIV viral load but does not alter hepatitis C virus (HCV) serum levels in HIV-HCV-co-infected haemophiliacs. AIDS 1998 0.77
255 Effect of intraduodenal administration of ursodeoxycholic acid on interdigestive interaction between gallbladder motility, pancreatic secretion and endocrine activity. Digestion 2004 0.77
256 Independent cycles of exocrine pancreatic secretion, hormones and gastroduodenal motility in healthy fasting humans: reassessment of a complex partnership. Neurogastroenterol Motil 1998 0.77
257 Gallbladder emptying is an important factor in fragment disappearance after shock wave lithotripsy. J Hepatol 1993 0.76
258 Fatal pneumonia in an AIDS patient coinfected with adenovirus and Pneumocystis carinii. Infection 2000 0.76
259 A comparative study of different enzyme immunosorbent assays for human tumor necrosis factor-alpha. J Immunol Methods 1996 0.76
260 [Recurrent intrahepatic cholestasis of pregnancy and chain-like choledocholithiasis in a female patient with stop codon in the ABDC4-gene of the hepatobiliary phospholipid transporter]. Z Gastroenterol 2008 0.76
261 [Method report: German S3-guideline "ascites, spontaneous bacterial peritonitis, hepatorenal syndrome"]. Z Gastroenterol 2011 0.76
262 Effects of different octreotide dosages on splanchnic hemodynamics and glucagon in patients with TIPS. Am J Gastroenterol 2001 0.76
263 Sclerotherapy is out--nearly. Endoscopy 1997 0.76
264 Cystatin C as an endogenous marker of glomerular filtration rate in renal transplant patients. Kidney Blood Press Res 2003 0.76
265 Portal hypertension is associated with increased mRNA levels of vasopressor G-protein-coupled receptors in human hepatic arteries. Eur J Clin Invest 2003 0.76
266 [TIPSS: technical and clinical results after 4 years]. Rofo 1998 0.75
267 [Chronic diarrhea in a 43-year-old patient]. Internist (Berl) 2003 0.75
268 Systemic iodine absorption during endoscopic application of radiographic contrast agents for endoscopic retrograde cholangiopancreaticography. Eur J Endocrinol 1994 0.75
269 [Guidelines by the German Society of Digestive and Metabolic Diseases for treatment of gallstones. German Society of Digestive and Metabolic Diseases]. Z Gastroenterol 2000 0.75
270 Gallbladder emptying during high-dose cholecystokinin infusions. Effect in patients with gallstone disease and healthy controls. Scand J Gastroenterol 1995 0.75
271 Bystander T-cell clones in chronic hepatitis C. Gastroenterology 1997 0.75
272 Which is the hen and which is the egg? Gastroenterology 2000 0.75
273 [Early detection of colorectal carcinoma]. Med Klin (Munich) 1996 0.75
274 Secretion, composition and flow of bile. Clin Gastroenterol 1983 0.75
275 Effects of ursodeoxycholic acid on splanchnic and systemic hemodynamics. A double-blind, cross-over, placebo-controlled study in healthy volunteers. Digestion 2000 0.75
276 Renal functional reserve is well maintained in patients with advanced liver cirrhosis and ascites. Scand J Gastroenterol 2002 0.75
277 Combined treatment of symptomatic gallbladder stones by extracorporeal shock-wave lithotripsy (ESWL) and instillation of methyl tert-butyl ether (MTBE). Dig Dis Sci 1991 0.75
278 Coinheritance of hereditary spherocytosis and reversibility of cirrhosis in a young female patient with hereditary hemochromatosis. Eur J Med Res 2009 0.75
279 [Is regression of cirrhosis in patients with hepatitis B infection possible? Regression of cirrhosis due to discontinuation of the inflammatory stimulus]. Dtsch Med Wochenschr 2013 0.75
280 Hepatitis C virus-associated mixed cryoglobulinaemia. Eur J Gastroenterol Hepatol 1997 0.75
281 Prophylaxis of first variceal bleeding: where does the truth lie. Endoscopy 1994 0.75
282 Virus-like particles in a case of acute hepatitis with human GB virus-C viraemia. Eur J Gastroenterol Hepatol 2001 0.75
283 [Orthotopic liver transplantation in a 33-year-old patient with fulminant hepatitis B and HIV infection]. Dtsch Med Wochenschr 2000 0.75
284 [Endemic celiac sprue and Hodgkin's disease in a 72-year-old patient]. Dtsch Med Wochenschr 2002 0.75
285 The anturane reinfarction trial. N Engl J Med 1980 0.75
286 [Guidelines for endoscopic studies in primary sclerosing cholangitis]. Z Gastroenterol 1992 0.75
287 [Endoscopic retrograde cholangiography in the diagnosis of liver diseases]. Z Gastroenterol 1984 0.75
288 [Short version of the updated S3 (level 3) guidelines for diagnosis and treatment of gallstones of the German Society for Digestive and Metabolic Diseases and the German Society for the Surgery of the Alimentary Tract]. Dtsch Med Wochenschr 2008 0.75
289 Labelling studies for structure elucidation of a new hydroxymetabolite of tramadol. Isotopes Environ Health Stud 1997 0.75
290 [Can hemorrhoids facilitate the transit of allergens from feces into the blood circulation?]. Dtsch Med Wochenschr 1999 0.75
291 [Demonstration of HAA antigen using the latex test]. Verh Dtsch Ges Inn Med 1972 0.75
292 [A patient with striking skull and stomach]. Dtsch Med Wochenschr 2010 0.75
293 [Prevention of recurrence with bismuth subsalicylate in a patient with recurrent and H2 receptor antagonist refractory duodenal ulcer]. Internist (Berl) 1989 0.75
294 [Use of ERCP in suspected bile duct and pancreatic cancer]. Z Gastroenterol 1992 0.75
295 [Acute variceal hemorrhage]. Z Gastroenterol Verh 1991 0.75
296 [Antineutrophil cytoplasmatic antibodies and their diagnostic significance as serum markers]. Dtsch Med Wochenschr 1999 0.75
297 [Australia-(hepatitis-B-) antigen. Properties and clinical significance]. Med Klin 1974 0.75
298 [Complications of liver cirrhosis]. Dtsch Med Wochenschr 2011 0.75
299 Variceal injection sclerotherapy. Baillieres Clin Gastroenterol 1991 0.75
300 [Tuberculosis--current therapeutic concepts]. Dtsch Med Wochenschr 2005 0.75
301 [A 61-year-old patient with thrombotic diathesis and liver function disorder]. Internist (Berl) 1990 0.75
302 [Extracorporeal shockwave lithotripsy of gallstones]. Z Gastroenterol Verh 1988 0.75
303 [Importance of endoscopy in intensive care medicine]. Krankenpfl J 1988 0.75
304 [Use of positron-emission tomography in oncology]. Dtsch Med Wochenschr 1996 0.75
305 [54-year-old patient with severe dyspnea 6 months after the implantation of a peritoneovenous shunt]. Internist (Berl) 1985 0.75
306 [2 patients with melena and hematochezia of undetermined origin]. Internist (Berl) 1985 0.75
307 [Pain therapy instead of antibiotics]. MMW Fortschr Med 2001 0.75
308 [Renal failure, thrombocytopenia and hemolytic anemia in a 36-year-old patient]. Internist (Berl) 2001 0.75
309 [Prevention of hemorrhage from esophageal varices]. Internist (Berl) 1987 0.75
310 [Paths of clinical research]. Dtsch Med Wochenschr 1998 0.75
311 [Is total body hyperthermia plus chemotherapy useful in pancreas carcinoma?]. Dtsch Med Wochenschr 2002 0.75
312 Labelling studies for structure elucidation of a new hydroxymetabolite of tramadol. Isotopes Environ Health Stud 1998 0.75
313 [Budd-Chiari syndrome in a patient with paroxysmal nocturnal haemoglobinuria]. Dtsch Med Wochenschr 2005 0.75
314 [62-year-old patient with abdominal pain and ascites. Angioneurotic edema (C1 esterase inhibitor deficiency)]. Dtsch Med Wochenschr 2010 0.75
315 [The therapy of viral hepatitis in HIV-infected patients]. Dtsch Med Wochenschr 1995 0.75
316 [Liver cirrhosis--case report]. Dtsch Med Wochenschr 2001 0.75
317 [Abdominal colic, arthralgia, petechial skin hemorrhage and glomerulonephritis after a subtropical stay]. Internist (Berl) 1990 0.75
318 [Chronic hepatitis C in type-II cryoglobulinemia and cutaneous vasculitis]. Dtsch Med Wochenschr 1994 0.75
319 [Therapy of acute cholecystitis]. Dtsch Med Wochenschr 1982 0.75
320 [Portal hypertension: beta-receptor blockers for the prevention of upper intestinal bleeding]. Dtsch Med Wochenschr 1992 0.75
321 [Hemobilia following erosion of the gastroduodenal artery and common bile duct by a pancreatic cyst]. Internist (Berl) 1988 0.75
322 Risk indicators of variceal bleeding. Z Gastroenterol 1988 0.75
323 [Endoscopy in patients at risk for bleeding]. Z Gastroenterol 1997 0.75
324 [The "Liver" Study Group: portal hypertension]. Z Gastroenterol Verh 1988 0.75
325 [The prevention of Pneumocystis carinii pneumonia in HIV infection]. Dtsch Med Wochenschr 1993 0.75
326 [Endoscopic diagnosis of gastritis]. Dtsch Med Wochenschr 1984 0.75
327 Secondary small cell neuroendocrine carcinoma of the cervix after radiotherapy for cervical squamous cell carcinoma. Int J Gynaecol Obstet 2007 0.75
328 [Percutaneous rotational lithotripsy of gallstones]. Z Gastroenterol 1991 0.75
329 [Fever with vesicular exanthema and pharyngitis in a 20-year-old patient (Mycoplasma pneumoniae associated Stevens-Johnson syndrome)]. Internist (Berl) 1988 0.75
330 [Diagnostic value of sonography and ERCP. Evaluation of the findings in 298 simultaneously studied patients]. MMW Munch Med Wochenschr 1979 0.75
331 [Use of sclerotherapy in patients with esophageal varices. Guidelines of the German Society of Digestive and Metabolic Diseases]. Z Gastroenterol 1993 0.75
332 Erythromycin, a motilin agonist, increases postprandial gallbladder emptying during therapy with ursodeoxycholic acid. Z Gastroenterol 1998 0.75
333 [Long-term sclerosing therapy of bleeding esophageal varices. A prospective course study]. Dtsch Med Wochenschr 1984 0.75
334 Efficacy and safety of ursodeoxycholic acid for dissolution of gallstone fragments: comparison with the combination of ursodeoxycholic acid and chenodeoxycholic acid. Hepatology 1991 0.75
335 [Applications of endoscopy in esophageal diseases. German Society of Digestive and Metabolic Diseases]. Z Gastroenterol 1994 0.75
336 [Adverse contrast medium-induced effects in ERCP]. Internist (Berl) 1997 0.75
337 [Palliative locoregional therapy for hilar cholangiocarcinoma: photodynamic therapy and brachytherapy]. Zentralbl Chir 2007 0.75
338 [Guidelines for endoscopic studies of infectious cholangitis]. Z Gastroenterol 1992 0.75
339 [Hepatology]. Z Gastroenterol 2010 0.75
340 [Pancreatitis as a diagnostic error in masked perforated duodenal ulcer with formation of a retroperitoneal abscess]. Internist (Berl) 1986 0.75
341 [HIV-associated cholangiopathy]. Dtsch Med Wochenschr 1994 0.75
342 [The Churg-Strauss syndrome with cerebral seizures and terminal kidney failure]. Dtsch Med Wochenschr 1997 0.75
343 [Palliative therapy of inoperable cholangiocarcinoma]. Dtsch Med Wochenschr 2002 0.75
344 Lymphangioma of the duodenum. (Diagnosis by endoscopic resection). Endoscopy 1977 0.75
345 [Liver cirrhosis--2: Complications and treatment]. Dtsch Med Wochenschr 2001 0.75
346 [Serologic diagnosis of liver fibrosis]. Dtsch Med Wochenschr 1999 0.75
347 Nephrogenic diabetes insipidus in a patient taking cidofovir. Lancet 1997 0.75
348 [A patient with a large liver tumor and long-term use of oral contraceptives]. Internist (Berl) 1985 0.75
349 [Interdisciplinary treatment of gallstones: surgery, endoscopy, lithotripsy. Report of experiences after 4 years]. Chirurg 1989 0.75
350 [Determination of the count rate for quality control of combined lung ventilation and perfusion scintigraphy: case report]. Nuklearmedizin 1997 0.75
351 Australia antigen in patients with acute and chronic liver disease, in blood donors and recipients. Vox Sang 1971 0.75
352 [Reconstruction of esophageal passage in functional disorders (achalasia, Zenker diverticulum, spasms)]. Langenbecks Arch Chir 1985 0.75
353 Does computed tomography improve patients selection for extracorporeal shock wave lithotripsy (ESWL) of radiolucent gallbladder stones? Z Gastroenterol 1992 0.75
354 [Current status of litholysis and lithotripsy of gallstones]. Chirurg 1988 0.75
355 Combination of extracorporeal shock-wave lithotripsy and dissolution of gallbladder stones with methyl tert-butyl ether: a randomized study. Hepatology 1994 0.75
356 [Susceptibility to edema in a 30-year-old patient]. Internist (Berl) 1987 0.75
357 [Treatment of calculi of the gallbladder by extracorporeal shock waves]. Verh Dtsch Ges Inn Med 1988 0.75
358 Indication, outcome and follow up of intensive care in patients with HIV-infection. Eur J Med Res 2000 0.75
359 [Clinical aspects and diagnosis of hepatitis C]. Dtsch Med Wochenschr 2000 0.75
360 [26-year-old patient with nausea and pressure pain in the upper abdomen]. Dtsch Med Wochenschr 2008 0.75
361 [Differential diagnosis of isolated increased SGOT level]. Dtsch Med Wochenschr 2003 0.75
362 Nonsurgical treatment of gallstones: where do we go from here? Hepatogastroenterology 1989 0.75
363 [Esophageal varices--technic and efficacy of sclerosing]. Verh Dtsch Ges Inn Med 1988 0.75
364 [Therapy of bleeding esophageal varices]. Dtsch Med Wochenschr 1983 0.75
365 [59-year-old patient with chronic joint symptoms and generalized weakness]. Internist (Berl) 2000 0.75
366 [Liver cirrhosis--1: Pathogenesis and diagnosis]. Dtsch Med Wochenschr 2001 0.75
367 [Recurring, severe upper abdominal pain in a 45 year old patient]. Internist (Berl) 2006 0.75
368 Resolution of refractory ascites after transcoronary septal ablation for hypertrophic obstructive cardiomyopathy in a cirrhotic patient. Z Gastroenterol 2008 0.75
369 [25-year-old patient with febrile infection, thrombopenia and hemolysis]. Internist (Berl) 1993 0.75
370 Changing role of invasive aspergillosis in AIDS--a case control study. J Infect 1998 0.75
371 Transient loss of T-cell reactivity in a patient with hepatitis C virus reinfection. Digestion 2001 0.75
372 Influence of long-term injection sclerotherapy on portal venous component of total liver perfusion measured by hepatosplenic radionuclide angiography. Hepatogastroenterology 1986 0.75
373 [A 33-year-old male patient with jaundice and right-sided epigastric pain]. Internist (Berl) 1993 0.75
374 [Upper-abdominal ultrasonography and ERCP? (author's transl)]. Dtsch Med Wochenschr 1979 0.75
375 [Do polymorphisms of the SDF1 and CCR2b genes modify the course of hepatitis C or HIV/HCV co-infection?]. Dtsch Med Wochenschr 2002 0.75
376 Biliary stones: treatment by shock-wave lithotripsy. Surg Endosc 1988 0.75
377 [52-year-old patient with pleural effusion after a stay in Cameroon]. Internist (Berl) 2000 0.75
378 [Atrial natriuretic factor. Initial results of possible significance in liver cirrhosis]. Leber Magen Darm 1987 0.75
379 Physical laws of cholesterol gallstone fragmentation. Eur J Clin Invest 1997 0.75
380 Effect of oral pancreatic enzyme administration on digestive function in healthy subjects: comparison between two enzyme preparations. Aliment Pharmacol Ther 1997 0.75
381 [Frequency of hepatitis B virus markers and antibodies to rubella viruses in patients with lymphoproliferative disorders (author's transl)]. Blut 1980 0.75
382 [Percutaneous drainage of fistula-associated abscesses and biliary fistulas]. Rofo 1989 0.75
383 [A 46-year-old patient with diarrhea, subfebrile temperatures and thrombophlebitis]. Internist (Berl) 1989 0.75
384 Determination of the newer quinolones levofloxacin and moxifloxacin in plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr Sci 2006 0.75
385 [4-year-old deglutition disorders in a 52-year-old patient]. Internist (Berl) 1982 0.75
386 [Control of infection in gastrointestinal endoscopy]. Dtsch Med Wochenschr 2006 0.75
387 [61-year-old patient with massive, recurrent gastrointestinal hemorrhage and aortic stenosis]. Internist (Berl) 1991 0.75
388 Non-operative management in a case of spontaneous splenic rupture in infectious mononucleosis. Z Gastroenterol 1995 0.75
389 [Immunoglobulin therapy for systemic lupus erythematosus]. Immun Infekt 1993 0.75
390 [Medical therapy of complications in liver cirrhosis]. Internist (Berl) 2007 0.75
391 [Therapy of cholecystolithiasis--current status]. Z Gastroenterol Verh 1990 0.75
392 [CT follow-up after transjugular intrahepatic portosystemic stent shunt (TIPSS)]. Rontgenpraxis 1995 0.75
393 [Acute biliary colic. Etiology, diagnosis and therapy]. Internist (Berl) 2003 0.75
394 Thermal coagulation of puncture lesions in the cholestatic rabbit liver with Nd: YAG laser and and high-frequency current. Hepatogastroenterology 1980 0.75
395 [Aftercare in patients with colorectal carcinomas]. Dtsch Med Wochenschr 1995 0.75
396 Enteric dysfunction in patients with asymptomatic HIV-infection versus patients with hypoproteinemia/hypalbuminemia and advanced HIV-infection. Eur J Med Res 2002 0.75
397 [Guidelines for patient monitoring in endoscopic examinations in gastroenterology. The German Society of Digestive and Metabolic Diseases]. Z Gastroenterol 1993 0.75
398 [Pharmacotherapy of cholesterol gallstones]. Med Monatsschr Pharm 1981 0.75
399 In vitro study to elucidate the physical laws concerning the fragmentation of both solitary and multiple artificial stones. Clin Investig 1993 0.75
400 [Antibiotic prevention and therapy of infectious complications in ERCP]. Leber Magen Darm 1992 0.75
401 [Cost-effectiveness of screening in familial adenomatous polyposis]. Dtsch Med Wochenschr 2002 0.75
402 [Libyan patient with chronic diarrhea]. Z Gastroenterol 1996 0.75
403 [Acute virus hepatitis. Recent findings]. Med Klin 1976 0.75
404 Catheter for the electrocoagulation of bile duct stenosis. Endoscopy 1984 0.75
405 [56-year-old man with acrocyanosis, livedo reticularis, renal failure and arterial hypertension. Cholesterol embolism syndrome (CES)]. Internist (Berl) 1998 0.75
406 [DMW special topic issue: Gastroenterology]. Dtsch Med Wochenschr 2000 0.75
407 [Pathogenesis and therapy of hemorrhage in esophageal varices]. Leber Magen Darm 1986 0.75
408 [Gallbladder lithiasis and common bile duct lithiasis treated with shock waves within the framework of a new interdisciplinary therapeutic approach to the biliary tract lithiasis. Apropos of 184 cases]. Chirurgie 1988 0.75
409 [Conservative therapy of acute liver failure]. Dtsch Med Wochenschr 1996 0.75
410 [Therapy and after-care of familial adenomatous polyposis and hereditary colorectal carcinoma without polyposis]. Dtsch Med Wochenschr 2000 0.75
411 Prediction of the lower esophageal sphincter pressure after oral molsidomine by sydnonimine plasma concentrations. Hepatogastroenterology 1999 0.75
412 [Muscle weakness, skin manifestations and para-hilar space-occupying lesions in a 59-year-old patient. Cushing disease and pulmonary lymph node tuberculosis]. Internist (Berl) 2003 0.75
413 Panel discussion: cholecystitis. Am J Surg 1989 0.75
414 [Muscle pain, scleroderma-like skin changes and eosinophilia following administration of a psychotropic drug]. Internist (Berl) 1992 0.75
415 Effect of omeprazole treatment on plasma concentrations of the gastric peptides, xenin, gastrin and somatostatin, and of pepsinogen. J Pept Res 1998 0.75
416 Reduction of transmural oesophageal variceal pressure by metoclopramide. J Hepatol 1991 0.75
417 The role of extracorporeal shock wave lithotripsy in gastroenterology. Ann Med 1990 0.75
418 [Diagnosis of acute liver failure]. Dtsch Med Wochenschr 1996 0.75
419 [Quincke edema as a manifestation of food allergy]. Internist (Berl) 1987 0.75
420 Images in hepatology. Herniation of the liver. J Hepatol 1997 0.75
421 [The prognosis of acute variceal hemorrhage is determined by liver function and not by the kind of therapy]. Z Gastroenterol Verh 1988 0.75